Ignite Creation Date:
2025-12-25 @ 12:05 AM
Ignite Modification Date:
2026-01-06 @ 8:37 AM
Study NCT ID:
NCT04701658
Status:
COMPLETED
Last Update Posted:
2021-11-16
First Post:
2021-01-07
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Real World Study of Bamlanivimab in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)
Sponsor:
Eli Lilly and Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-02-01
Start Date Type:
ACTUAL
Primary Completion Date:
2021-06-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-06-22
Completion Date Type:
ACTUAL
First Submit Date:
2021-01-07
First Submit QC Date:
None
Study First Post Date:
2021-01-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-11-11
Results First Submit QC Date:
None
Results First Post Date:
2021-11-16
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-11-11
Last Update Post Date:
2021-11-16
Last Update Post Date Type:
ACTUAL